▲ Peaking
Business
Pfizer Signs $1.5 Billion Deal With Blackstone to Fund Weight-Loss-Drug Development
Pfizer has secured up to $1.5 billion from Blackstone to fund the development of its obesity and weight-loss drugs.
Blackstone Life Sciences
1 trends tracked about this subject — the full history, oldest to newest below.